Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons

  1. Xinyi Jenny He
  2. Janki Patel
  3. Connor E Weiss
  4. Xiang Ma
  5. Brenda L Bloodgood
  6. Matthew Ryan Banghart  Is a corresponding author
  1. University of California San Diego, United States
  2. University of California, San Diego, United States

Abstract

neuronal sensitivity to neuromodulators and therapeutic drugs. Mu and Delta opioid receptors (MORs and DORs) can interact when overexpressed in the same cells, but whether co-expression of endogenous MORs and DORs in neurons leads to functional interactions is unclear. Here, in mice, we show that both MORs and DORs inhibit parvalbumin-expressing basket cells (PV-BCs) in hippocampal CA1 through partially occlusive signaling pathways that terminate on somato-dendritic potassium channels and presynaptic calcium channels. Using photoactivatable opioid neuropeptides, we find that DORs dominate the response to enkephalin in terms of both ligand-sensitivity and kinetics, which may be due to relatively low expression levels of MOR. Opioid-activated potassium channels do not show heterologous desensitization, indicating that MORs and DORs signal independently. In a direct test for heteromeric functional interactions, the DOR antagonist TIPP-Psi does not alter the kinetics or potency of either the potassium channel or synaptic responses to photorelease of the MOR agonist DAMGO. Thus, aside from largely redundant and convergent signaling, MORs and DORs do not functionally interact in PV-BCs in a way that impacts somato-dendritic potassium currents or synaptic transmission. These findings imply that crosstalk between MORs and DORs, either in the form of physical interactions or synergistic intracellular signaling, is not a preordained outcome of co-expression in neurons.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures.

Article and author information

Author details

  1. Xinyi Jenny He

    Biological Sciences, University of California San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3884-0596
  2. Janki Patel

    University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Connor E Weiss

    University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Xiang Ma

    University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9164-8608
  5. Brenda L Bloodgood

    University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4797-9119
  6. Matthew Ryan Banghart

    University of California San Diego, San Diego, United States
    For correspondence
    mbanghart@ucsd.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7248-2932

Funding

National Institute on Drug Abuse (R00DA034648)

  • Matthew Ryan Banghart

National Institute of General Medical Sciences (R35GM133802)

  • Matthew Ryan Banghart

National Institute of Neurological Disorders and Stroke (U01NS113295)

  • Matthew Ryan Banghart

National Institute of Mental Health (U01NS113295)

  • Matthew Ryan Banghart

Brain and Behavior Research Foundation (NARSAD Young Investigators Award)

  • Matthew Ryan Banghart

Esther A. and Joseph Klingenstein Fund (Klingenstein-Simons Fellowship in Neuroscience)

  • Matthew Ryan Banghart

National Institute of General Medical Sciences (T32GM007240)

  • Xinyi Jenny He

National Institute of Neurological Disorders and Stroke (R01NS111162)

  • Brenda L Bloodgood

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures were performed in accordance with protocols approved by the University of California San Diego Institutional Animal Care and Use Committee (IACUC) following guidelines described in the the US National Institutes of Health Guide for Care and Use of Laboratory Animals (UCSD IACUC protocol S16171). All surgery was performed under isoflurane anesthesia.

Reviewing Editor

  1. Gregory Scherrer

Publication history

  1. Preprint posted: April 24, 2021 (view preprint)
  2. Received: May 20, 2021
  3. Accepted: November 16, 2021
  4. Accepted Manuscript published: November 17, 2021 (version 1)
  5. Accepted Manuscript updated: November 17, 2021 (version 2)
  6. Version of Record published: December 29, 2021 (version 3)

Copyright

© 2021, He et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,120
    Page views
  • 166
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xinyi Jenny He
  2. Janki Patel
  3. Connor E Weiss
  4. Xiang Ma
  5. Brenda L Bloodgood
  6. Matthew Ryan Banghart
(2021)
Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons
eLife 10:e69746.
https://doi.org/10.7554/eLife.69746

Further reading

    1. Developmental Biology
    2. Neuroscience
    Ashtyn T Wiltbank et al.
    Research Article

    Efficient neurotransmission is essential for organism survival and is enhanced by myelination. However, the genes that regulate myelin and myelinating glial cell development have not been fully characterized. Data from our lab and others demonstrates that cd59, which encodes for a small GPI-anchored glycoprotein, is highly expressed in developing zebrafish, rodent, and human oligodendrocytes (OLs) and Schwann cells (SCs), and that patients with CD59 dysfunction develop neurological dysfunction during early childhood. Yet, the function of Cd59 in the developing nervous system is currently undefined. In this study, we demonstrate that cd59 is expressed in a subset of developing SCs. Using cd59 mutant zebrafish, we show that developing SCs proliferate excessively and nerves may have reduced myelin volume, altered myelin ultrastructure, and perturbed node of Ranvier assembly. Finally, we demonstrate that complement activity is elevated in cd59 mutants and that inhibiting inflammation restores SC proliferation, myelin volume, and nodes of Ranvier to wildtype levels. Together, this work identifies Cd59 and developmental inflammation as key players in myelinating glial cell development, highlighting the collaboration between glia and the innate immune system to ensure normal neural development.

    1. Neuroscience
    Arefeh Sherafati et al.
    Research Article Updated

    Cochlear implants are neuroprosthetic devices that can restore hearing in people with severe to profound hearing loss by electrically stimulating the auditory nerve. Because of physical limitations on the precision of this stimulation, the acoustic information delivered by a cochlear implant does not convey the same level of acoustic detail as that conveyed by normal hearing. As a result, speech understanding in listeners with cochlear implants is typically poorer and more effortful than in listeners with normal hearing. The brain networks supporting speech understanding in listeners with cochlear implants are not well understood, partly due to difficulties obtaining functional neuroimaging data in this population. In the current study, we assessed the brain regions supporting spoken word understanding in adult listeners with right unilateral cochlear implants (n=20) and matched controls (n=18) using high-density diffuse optical tomography (HD-DOT), a quiet and non-invasive imaging modality with spatial resolution comparable to that of functional MRI. We found that while listening to spoken words in quiet, listeners with cochlear implants showed greater activity in the left prefrontal cortex than listeners with normal hearing, specifically in a region engaged in a separate spatial working memory task. These results suggest that listeners with cochlear implants require greater cognitive processing during speech understanding than listeners with normal hearing, supported by compensatory recruitment of the left prefrontal cortex.